MediciNova Receives Notice of Allowance for Second Patent Covering MN-166 (ibudilast) for the Treatment of Glioblastoma - GlobeNewswire

MediciNova Receives Notice of Allowance for Second Patent Covering MN-166 (ibudilast) for the Treatment of Glioblastoma  GlobeNewswire

Comments

Popular posts from this blog

UConn Health's Caryl Ryan Recognized as Infection Prevention ... - University of Connecticut

Marburg virus disease